Quadricuspid aortic valve (QAV) is a rare congenital cardiac anomaly with prevalence less than 0.01% in autopsy series. It can be found as an isolated anomaly, and the patient may be asymptomatic, but is often associated with aortic insufficiency in 68% of the cases. Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are currently used as a diagnostic and follow-up method for this anomaly. The objective of the present paper is through the clinical case report of a 60 year old patient submitted to surgical correction of QAV, to relate some clinical aspects of the disease and to discuss the anesthetic management for this group of patients, in addition, emphasizing the importance and the increasing use of the TEE in the intraoperative period in cardiac surgeries.
Introduction
There are two classification systems for QAV: The Hurwitz & Roberts [1] , in which the QAV is classified according to the size of the supranumerary cusp into seven categories from A to G, and to which Vali [2] has added the H type (Figure 1) . And the system proposed by Nakamura et al. [3] , in which the classification is based on the position of the supranumerary cusp, whether it is located between the right and left coronary cusps (type 1), between the right and non-coronary cusps (type 2), between left and non-coronary cusps (type 3), and type 4 when there are four equal sized cusps present.
Functionally, the QAV often presents itself as pure aortic regurgitation (AR).
Tutarel & Westhoff-Bleck [4] reported that the functional status of QAV was regurgitant in 74.7%, combined stenosis and regurgitation in 8.4%, stenotic in 0.7%, and normally functioning in 16.2%.
QAV may occur in up to 32% of the cases in association with a variety of heart disorders like, atrial septal defect [5] , ventricular septal defect [6] , patent ductus arteriosus [7] , tetralogy of Fallot [8] , sinus of Valsalva fistula [9] , subaortic fibromuscular stenosis [10] , mitral valve regurgitation [11] , mitral valve prolapse [12] , hypertrophic non-obstructive cardiomyopathy (with echocardiographic evidence of massive left ventricular hypertrophy and asymmetric septal hypertrophy) [13] , and transposition of the great arteries [14] .
The early diagnosis of this pathology is of great importance due to the serious consequence that this can cause: severe aortic regurgitation, which may lead, in extreme cases, to left ventricular failure. In addition, there is a probable increase in the risk of developing infective endocarditis (IE) and possibility of association with anomalous origin of coronary artery ostia. Thus, patients with this congenital abnormality should have a permanent strict medical follow-up, since the diagnosis, and must undergo surgical correction (if indicated) avoiding evolution to left ventricular disease (ventricular failure) [15] [16] .
TEE, in addition to its importance in the diagnosis of the disease and the follow-up of these patients, has been gaining great importance in its intraoperative use in cardiac surgeries due to the ease of real-time hemodynamic monitoring, analysis of anatomical structures and early identification of complications such as ischemia, air embolism or pericardial effusion [17] [18] .
The surgical indications for QAV are severe AR [19] , severe aortic stenosis [20] , or dysfunctional QAV associated with other lesions, such as occlusion of the left coronary ostium [19] . The treatment for QAV consists on surgical correction, either by valve replacement or valve repair. Thus, the technique of choice for the procedure is usually determined on the disease severity, condition of QAV, and surgeon's preference [21] . Postoperative complications are not frequent, and they include progressive AR, transient ischemic attack, cardiac arrest and postoperative complete heart block [22] . The overall survival rates of QAV patients were 89.9% and 84.9% at 5-and 10-year follow-up, respectively [19] .
Case Report
A 60-year-old male patient has hypertensive, on regular use of simvastatin and amlodipine. Diagnosis of QAV was performed in 2017 when it was admitted to Cardiology department after the onset of dyspnea symptoms at medium effort.
The TTE showed severe aortic insufficiency with dilation of the aorta root (4 Open Journal of Anesthesiology cm) and ascending aorta (5.2 cm), ejection fraction of 49%, enlargement of the left chambers, borderline left ventricle function and aortic reflux.
Coronary angiography is without severe obstructive lesions, with mild LV dysfunction. Laboratory tests within the limits of normality electrocardiogram with sinus rhythm and evidence of increased left chambers. Chest x-ray: Dilation of ascending aorta. Patient hospitalized in the Cardiology sector of the Pedro Ernesto University Hospital (HUPE) for clinical compensation and surgical correction. Surgical proposal: aortic valve replacement and ascending aortic prosthesis.
The patient was admitted to the surgical theater, decompensated, with blood pressure 140/70 mmHg, SpO2: 88% in ambient air, heart rate of 90 bpm. After entry into the operating room, he was premedicated with intravenous midazolam 3 mg and then pre-oxygenated under face mask. Punctured right radial artery for continuous invasive blood pressure monitoring, followed by anesthetic induction with etomidate 10 mg, fentanyl 200 mcg and muscle relaxation with rocuronium 50 mg. Orotracheal intubation was performed with 8 mm cuff under direct laryngoscopy. Hypnosis was maintained with sevoflurane 1% -3%. Then 2 g cefazolin and tranexamic acid (Transamin) 2.7 g were infused, puncturing right internal jugular vein with the aid of ultrasonography.
Before beginning the surgery, a TEE probe was introduced to monitor cardiac function and visualize structures of interest (Image 1). The patient was anticoagulated with 25,000 I.U. heparin, and the initial activated clotting time (ACT) of 890 seconds was used. During extracorporeal circulation (ECC), propofol was started in a continuous infusion pump to maintain hypnosis. The ECC lasted for Image 1. Mid-esophageal cut short aortic valve obtained through intraoperative TEE exam, demonstrating dilation of the aortic root (4.5 cm).
Discussion
QAV is a rare congenital cardiac anomaly of the aortic valve, occurring in a prevalence of 0.008% and 0.043% in autopsy and echocardiographic studies, respectively [23] . In the literature, there is a discrete male predominance in relation to women, with a male-to-female ratio of 1.6:1. The diagnosis is most commonly performed from the 5th decade of life, with a mean age of 50.7 years, when these patients become clinically symptomatic. This fact is probably a consequence of progressive aortic valve injury resulting from this malformation, making valvular insufficiency more expressive after 5 decades, leading to the appearance (or exacerbation) of clinical manifestations consistent with aortic insufficiency. Due to the progressive character of aortic valve injury over the years, it is important to diagnose this malformation early, avoiding, through strict follow-up of these patients, the evolution to left ventricular disease (LV failure) [24] .
Before the advent of Echocardiography, the diagnosis of QAV was usually made during cardiac surgeries or autopsies. The wide use of the echocardiogram, especially after 1980, facilitated the identification of QAV and, consequently, made this diagnosis more frequent. Konrad et al. in his review, found that 82% of cases of QAV were diagnosed after the 1980s [15] . Although TTE has an important role in detecting some congenital heart defects, it has a limitation in the identification of QAV due to its worse acoustic window for the study of the aortic valve. The TEE allows a higher image resolution of this valve (due to the great proximity between the esophagus and the left atrium and absence of bones or lung tissue), allowing a better definition of the morphology and degree of valvular dysfunction, as well as identifying the mechanisms responsible for its failure [18] [25] . The typical QAV image on the echocardiogram was described by Herman in 1984 and has since become pathognomonic of the disease. In the diastole, it shows the typical "cross" or "X" valve closure (Image 2) different from the characteristic "Y" closure of the normal tricuspid aortic valve and, in systole, the rectangular opening, different from the typical triangular opening of the normal valve [26] . Open Journal of Anesthesiology Image 2. Mid-esophageal cut short aortic valve obtained through intraoperative TEE exam, demonstrating a pathognomonic image of QAV ("X" or "cross" valve closure during diastole).
The pathophysiology of aortic insufficiency, presenting in 68% of the cases of patients with QAV, is still not very well established in the literature, and there are some theories that try to explain it: 1) valve injury due to unequal distribution of stress forces due to anatomical abnormalities of the cusps with subsequent development of fibrosis and calcification; 2) incomplete coaptation of the cusps by unequal sizes between them, preventing an ideal coaptation, which would be aggravated by fibrosis and posterior calcification; 3) dilation of the aortic root and prolapse of the cusps [24] [27]. In conclusion, it is believed that the development of thickening and valvar calcification, occurring throughout life, propitiated by the factors discussed above, are responsible for valvular insufficiency in QAV.
QAV, for the most part, is an isolated anomaly, but occasionally it may be associated with other cardiac malformations. The most commonly found in the literature are those related to coronary artery ostia (single coronary ostia, anomalous positions or obstruction) anomalies, reported in 10% of the cases described [13] . Other cardiac malformations associated with QAV less frequently found were: ventricular septal defect, patent ductus arteriosus, and mitral valve malformation [14] [27]. In addition, there appears to be an increased risk of developing IE in patients with QAV, especially in those patients who have valves with anatomically unequal cusps because of increased flow disturbances. Thus, prophylaxis for IE should be instituted for all patients with QAV who will undergo procedures involving bacteremia [28] .
The treatment of QAV will depend on the abnormalities found in the valve, Open Journal of Anesthesiology The heart rate should be maintained near the upper limits of normality (80 -100 beats/min). Bradycardia and tachycardia should be avoided, as they may cause, respectively, regurgitant volume increase and contribution to myocardial ischemia. Cardiac output may still be improved by mild decreases in systemic vascular resistance and compensatory increase in cardiac preload (volume replacement should be performed with caution, since overexposure may easily result in pulmonary edema) [30] .
Angina may occur even in the absence of coronary disease, as the myocardial oxygen demand is increased due to muscle hypertrophy and LV dilation, while the myocardial blood supply is reduced due to the low diastolic pressures in the aorta as a result of regurgitation. This fact, together with the risk of QAV association with coronary artery ostia anomalies, shows the importance of strict monitoring for myocardial ischemia in patients with valvular heart disease, especially when submitted to surgical stress. 
Conclusions
Despite the low prevalence of QAV, its clinical significance comes from the fact that 68% of patients with this valvular heart disease have some degree of aortic insufficiency. The early diagnosis of this congenital malformation is of fundamental importance, since the lesion to the AV is progressive and may lead over the years to severe aortic insufficiency, LV failure and finally congestive heart failure.
The management of anesthesia in these patients should include care that optimizes cardiac output by increasing the effective LV systolic volume and decreasing regurgitant volume. Heart rate should be maintained near the upper limits of normality. Bradycardia and tachycardia should be avoided. Cardiac output may still be improved by mild decreases in systemic vascular resistance and compensatory caution increase in cardiac preload.
The Echocardiographic study has a recognized role in the diagnosis (supernumerary aortic valve detection) and in the follow-up of patients with QAV. In the last decades, the intraoperative use of TEE has been gaining prominence, especially in cardiac surgeries. This is because a complete examination during the intraoperative period not only characterizes the hemodynamic profile of the patient but also can lead to modifications in the surgical approach in up to 25% of the exams. Thus, based on the scientific evidence and direct impact on the final outcomes of cardiac surgeries (decrease in morbidity and mortality), the use of intraoperative TEE has been widely discussed by the Societies of Cardiology and Anesthesiology in order to define guidelines for its use.
